Skip to main content

Table 2 Recurring patients

From: Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population

Patient No. Initial stage EBV DNA at diagnosis (copies/ml) EBV DNA at the end of treatment (copies/ml) EBV DNA at recurrence (copies/ml) Time to recurrence (months)
1 T2N3 290,000 < 350 2,135 14
2 T4N2 9,600 < 350 900 25
3 T3N2 12,745 < 350 < 350 18
4 T2N1 3,300 < 350 < 350 26
5 T2N3 87,425 7,820 4,398,000 11
6 T3N2 1,240 < 350 9,185 12
7 T2N2 7,290 1,560 15,290 12
  1. EBV = Epstein-Barr Virus.
  2. DNA = Deoxyribonucleic acid.